Alphabetical listing of all products

A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z

Prices
  • 5 mg - 62 EUR
  • 25 mg - 248 EUR
  • 100 mg - 744 EUR

VX-702

VX-702 is a second-generation, orally active p38 MAP kinase inhibitor, developed for the potential treatment of inflammation, rheumatoid arthritis and cardiovascular diseases. In June 2005, a phase II clinical trial of VX-702 was initiated in patients with rheumatoid arthritis.

catalogue number: V153
synonyms: -
CAS: 745833-23-2
MW: 404.32 g/mol

References
Curr Opin Investig Drugs. 2006 Nov;7(11):1020-5. PMID: 17117592